A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Bluebird bio Inc’s current trading price is -60.14% away from its 52-week high, while its distance from the 52-week low is 35.71%. The stock’s price range for this time frame has been between $2.52 and $8.58. The trading volume of the company’s shares in the Healthcare reached around 4.99 million for the day, which was evidently higher than the average daily volume of 3.49 million over the last three months.
Currently, the stock price of Bluebird bio Inc (BLUE) is $3.42. In the most recent trading session, the stock underwent a significant upswing, peaking at $3.43 after opening at $3.10. The stock touched a low of $3.07 before closing at $3.04.
In terms of market performance, Bluebird bio Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $8.58 on 12/05/22, while the lowest value was $2.52 on 10/13/23.
How Financial Performance Impacts Market Capitalization
Bluebird bio Inc (BLUE) has experienced a quarterly decline of 0.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 373.94M and boasts a workforce of 323 employees.
Decoding Analysts’ Ratings for Bluebird bio Inc
As of right now, 3 analysts are rating Bluebird bio Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 6 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 2 analysts are rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.33, with a change in price of +0.03. Similarly, Bluebird bio Inc recorded 3,985,287 in trading volume during the last 100 days, posting a change of +0.88%.
How BLUE’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for BLUE stands at 1.36. Similarly, the long-term debt-to-equity ratio is also 1.04.
BLUE Stock Stochastic Average
The raw stochastic average for Bluebird bio Inc over the last 50 days is presently at 75.63%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 71.57%. Further, the company’s Stochastic %K and %D values for the last 20 days were 54.90% and 51.42%, respectively.
BLUE Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -50.58%. However, over the past six months, we’ve seen a stronger performance of -8.56%. The price of BLUE fallen by 23.02% over the last 30 days. And in the last five days, it has surged by 14.77%.